General Node negative Node Positive Clin / Path features Role Plays
100
RT-PCR
How is the technique used for ODX test processing?
100
What are the validation studies in N0 setting?
What are the validation studies in N0 setting?
100
What are the node positive studies?

TransATAC
SWOG
RxPONDER
What are the node positive studies?
100

Grade 1, size >3
Grade 2, size >2
Grade 3, size >3
What is the definition of clinical High risk in TAILORx?
100
TailorX
Newbie - N0
200
21 genes

How many genes is the panel of ODX?
200
28%
What is the absolute chemotherapy benefit in B20?
200

inclusion of the age and relevance to CT benefit in primary endpoint
ARM A & D excluded from the study
Pre-defined cut points for menopausal status
no statistical significant iDFS difference between two subgroups
Name 2 differences between TAILORx and RxPONDER
200
43%
What is the percentage of patients that presented with high clinical risk but fell in low risk category with ODX - TAILORx?
200
RxPONDER
RxPONDER
Newbie - N1
300
Level 1b

What is the level of ODX data in NSABP-B20?
300
6.5%
For a RS of 23 for a pre-menopausal women, what is the CT benefit?
300
2.9%
What is the benefit of CT for pre-menopausal women in RxPONDER
300
N0/ N1 post-menopausal , more than 0.5 cm

Who is eligible for ODX according to NCCN guidelines?
300
Patient centricity
Patient centricity
User - N0
Clinical path features (general)
400
What is the level of ODX data after RxPONDER and TailorX?
Level 1a
What is the level of ODX data after RxPONDER and TailorX?
400
13%
What is the distance recurrence rate for the ARM D in TAILORx?
400
How is menopausal status defined in RxPONDER?
pre-menopausal: less than 6 months since the last period
post-menopausal: more than 12 month since last period
How is menopausal status defined in RxPONDER?
400
No longer put to vote - not recommended

Where does St Gallen stands when it comes to incorporation of ki-67 in treatment paradigm
400
patient centricity
patient centricity
ki-67 driver for ODX prescription
USER
500
1-10
According to the 8th pathologist association criteria, which RS range recategorizes the patient from stage 2 to stage 1
500
Primary: IDFS
Secondary: OS, DRFI
Primary: IDFS
Secondary: OS, DRFI
What are the primary and secondary endpoints in TAILORx?
500
Primary: iDFS with adjustment in menopausal status
Secondary: OS
What are the endpoints in RxPONDER?
500
Node status
Ki-67
Age
Tumor Size
Grade
Clinical H/L
All
In the German study what were the stratification of patients
500
:)
Oncotype is not for everyone as it is expensive






Oncotype DX double Jeopardy

Press F11 for full screen mode



Limited time offer: Membership 25% off


Clone | Edit | Download / Play Offline